Q3 2026 13F filing
Updated 6 days ago83 disclosed positions worth $9.9B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PROTAGONIST THERAPEUTICS INC | $713.1M | 5.06M | 7.19% | — |
| 2 | A ARGENX SE | $682.3M | 711.6K | 6.88% | — |
| 3 | C CG ONCOLOGY INC | $603.6M | 8.51M | 6.08% | — |
| 4 | I IRHYTHM HOLDINGS INC | $354.5M | 3.12M | 3.57% | — |
| 5 | I INSMED INC | $353.4M | 3.10M | 3.56% | — |
| 6 | T TANGO THERAPEUTICS INC | $350.5M | 14.05M | 3.53% | — |
| 7 | E ERASCA INC | $329.1M | 22.45M | 3.32% | — |
| 8 | S SPYRE THERAPEUTICS INC | $328.7M | 3.69M | 3.31% | — |
| 9 | R RADNET INC | $319.2M | 4.63M | 3.22% | — |
| 10 | T TARSUS PHARMACEUTICALS INC | $273.9M | 3.48M | 2.76% | — |
| 11 | Z ZAI LAB LTD | $272.6M | 10.35M | 2.75% | — |
| 12 | R REPLIGEN CORP | $266.3M | 1.39M | 2.68% | — |
| 13 | G GUARDANT HEALTH INC | $264.2M | 1.48M | 2.66% | — |
| 14 | C CELCUITY INC | $262.8M | 3.30M | 2.65% | — |
| 15 | O ORUKA THERAPEUTICS INC | $261.4M | 3.14M | 2.64% | — |
| 16 | N NATERA INC | $248M | 600.0K | 2.50% | — |
| 17 | C CYTOKINETICS INC | $188.6M | 2.86M | 1.90% | — |
| 18 | U UROGEN PHARMA LTD | $184.6M | 4.54M | 1.86% | — |
| 19 | E ESTABLISHMENT LABS HLDGS INC | $171.1M | 2.67M | 1.72% | — |
| 20 | X XENCOR INC | $170.3M | 6.83M | 1.72% | — |
| 21 | M MADRIGAL PHARMACEUTICALS INC | $157.6M | 312.8K | 1.59% | — |
| 22 | I IMMUNOCORE HLDGS PLC | $147.5M | 4.87M | 1.49% | — |
| 23 | S STOKE THERAPEUTICS INC | $146.2M | 5.62M | 1.47% | — |
| 24 | A ACADIA PHARMACEUTICALS INC | $144M | 7.14M | 1.45% | — |
| 25 | K KODIAK SCIENCES INC | $141.1M | 1.49M | 1.42% | — |
| 26 | G GH RESEARCH PLC | $139.3M | 5.93M | 1.40% | — |
| 27 | C COMPASS PATHWAYS PLC | $136.2M | 10.95M | 1.37% | — |
| 28 | N NEUROCRINE BIOSCIENCES INC | $133.7M | 942.7K | 1.35% | — |
| 29 | R ULTRAGENYX PHARMACEUTICAL IN | $128.2M | 8.53M | 1.29% | — |
| 30 | K KAILERA THERAPEUTICS INC | $123.1M | 10.78M | 1.24% | — |
| 31 | B BELITE BIO INC | $121.5M | 715.3K | 1.22% | — |
| 32 | I IMMATICS N.V | $118.7M | 13.52M | 1.20% | — |
| 33 | Q REPLIMUNE GROUP INC | $112.4M | 8.49M | 1.13% | — |
| 34 | I IMMUNOVANT INC | $107.3M | 3.18M | 1.08% | — |
| 35 | P PTC THERAPEUTICS INC | $104.7M | 1.62M | 1.05% | — |
| 36 | V VIRIDIAN THERAPEUTICS INC | $101.1M | 4.91M | 1.02% | — |
| 37 | C CASTLE BIOSCIENCES INC | $98.7M | 2.78M | 0.99% | — |
| 38 | Q UNIQURE NV | $95.2M | 3.94M | 0.96% | — |
| 39 | C COGENT BIOSCIENCES INC | $73.9M | 2.31M | 0.75% | — |
| 40 | G STRUCTURE THERAPEUTICS INC | $71.4M | 2.28M | 0.72% | — |
| 41 | A AXOGEN INC | $69.6M | 1.66M | 0.70% | — |
| 42 | T TAYSHA GENE THERAPIES INC | $66M | 13.56M | 0.67% | — |
| 43 | O ORCHESTRA BIOMED HLDGS INC | $59.4M | 9.56M | 0.60% | — |
| 44 | V VERASTEM INC | $54.1M | 6.72M | 0.55% | — |
| 45 | D DANAHER CORP DEL | $51M | 230.0K | 0.51% | — |
| 46 | H HINGE HEALTH INC | $48.6M | 500.0K | 0.49% | — |
| 47 | R ROCKET PHARMACEUTICALS INC | $46.5M | 17.69M | 0.47% | — |
| 48 | S SOLID BIOSCIENCES INC | $42.7M | 5.91M | 0.43% | — |
| 49 | N NEUROGENE INC | $42.1M | 1.51M | 0.42% | — |
| 50 | C CULLINAN THERAPEUTICS INC | $36.3M | 2.36M | 0.37% | — |